This review presents an introduction to Raman scattering and describes the various Raman spectroscopy, Raman microscopy, and chemical imaging techniques that have demonstrated utility in biocolloidal self-assemblies, pharmaceutical drug delivery systems, and pulmonary research applications. Recent Raman applications to pharmaceutical aerosols in the context of pulmonary inhalation aerosol delivery are discussed. The "molecular fingerprint" insight that Raman applications provide includes molecular structure, drug-carrier/ excipient interactions, intramolecular and intermolecular bonding, surface structure, surface and interfacial interactions, and the functional groups involved therein. The molecular, surface, and interfacial properties that Raman characterization can provide are particularly important in respirable pharmaceutical powders, as these particles possess a higher surface-area-to-volume ratio; hence, understanding the nature of these solid surfaces can enable their manipulation and tailoring for functionality at the nanometer level for targeted pulmonary delivery and deposition. Moreover, Raman mapping of aerosols at the micro-and nanometer level of resolution is achievable with new, sophisticated, commercially available Raman microspectroscopy techniques. This noninvasive, highly versatile analytical and imaging technique exhibits vast potential for in vitro and in vivo molecular investigations of pulmonary aerosol delivery, lung deposition, and pulmonary cellular drug uptake and disposition in unfixed living pulmonary cells.
INTRODUCTION-THE RAMAN EFFECT
Elastic scattering of photons (Rayleigh scattering) from incoming light occurs with the same frequency (energy) and hence wavelength as the incident photons, as depicted in Figure 1a . The Raman effect was discovered by the Indian physicist Sir Chandrasekhara Venkata Raman, who was awarded the Nobel Prize in Physics in 1930 for his seminal discoveries on the "molecular diffraction of light" in liquids and the "diffusion of gases." [1] [2] [3] The Raman effect is the process whereby inelastic scatter of outgoing photons occurs, which is typically a small fraction of scattered photons at a different and higher optical frequency from the incident photonic frequency. Raman shift in wave numbers (cm -1
) is defined as the difference between the incident light, λ incident , and the Raman scattering of photons, λ scattered . In other words, the vibrational energy of the scattering molecule is the energy difference between the incident and Raman-scattered photons. A typical Raman spectrum consists of a plot of the scattered light as a function of the energy difference. Figure 1 illustrates the scattering effects that give rise to the Raman effect, which occurs when the incident photon interacts with the electric dipole of the molecule, pertubating the molecule's electrical field. This is a quantum mechanical phenomenon, whereby the scattering can be described as a vibrational energy change resulting from an excitation to a lower energy state rather than a real electronic transition. The scattered photon will have a longer wavelength (lower energy) than the incoming photon (exciting photon), resulting in a Stokes Raman scattering, as depicted in Figure 1b . The Stokesshifted Raman spectrum (Figure 1b) is stronger than the anti-Stokes-shifted spectrum (Figure 1c) , and both contain the same frequency information. The ratio of both spectra can provide information on temperature.
Vibrational energy and bond-stretching frequency are determined by several molecular properties, including atom types, atomic mass, molecular geometry, hydrogen bonding, and bond order (single bond vs double bond vs triple bond). It is important to recognize that Raman scattering measures molecular polarizability (the extent to which an electronic cloud can be distorted), as molecular vibrations can affect polarizability, providing useful information on molecular dipoles. Hence, both intramolecular and intermolecular vibrations are Raman-active. The Raman-active vibration selection rule states that there must be a change in polarizability accompanying a vibration. In other words, strong Raman scattering occurs with a larger change in polarizability of distributed electron clouds, as found in a carbon-carbon double bond where the π-electron cloud is easily distorted because bond stretching and/or bending causes a significant change in the electron cloud density and induced-dipole moment. Hence, aromaticity is associated with strong symmetric vibration and a strong Raman band. Strong Raman scatters have symmetrical vibrations and include phenyl moieties and other aromatic moieties, 4 sulfide bonds, and carbon-carbon single and double bonds, which are all common structural characteristics of many pharmaceutical molecules. In contrast, the O-H bond is inherently highly polar because of the uneven distribution of the electron cloud favoring the oxygen atom; hence, polarizability is low and so is the Raman scattering. This is due to the fact that a highly polar moiety, such as the O-H bond, has a weak vibration and low Raman band, which is ideal for aqueous systems.
It is noted that infrared (IR) spectroscopy is also commonly used in molecular characterization of pharmaceutical materials, as it is complementary to Raman spectroscopy; however, sample preparation is required. Another benefit of Raman is that there tends to be less spectral overlap with common pharmaceutical excipients. 5 Additionally, pharmaceutical drug product containers (eg, glass and plastic) absorb mid-IR light due mainly to C-H vibrations, so noninvasive drug product identification and on-line process (in situ) monitoring is not possible with IR, as it is with Raman spectroscopy (to be discussed below). 6 Unlike Raman spectroscopy (symmetric vibration), IR requires a dipole moment change (ie, asymmetric vibration). Accordingly, weak Raman scatters tend to be strong IR absorbers and include bond vibrations present in polar moieties, such as carbonyl and hydrogen-bonded hydroxyl groups, since they display asymmetric (IR) rather than symmetric (Raman) vibrations. The various types of Raman spectroscopy and their applications are summarized in Table 1 .
Several excellent reviews [7] [8] [9] discuss in detail the Raman effect, the various types of Raman spectroscopy, Raman band frequencies, 10, 11 and the many applications of Raman spectroscopy in chemistry, biology, material science, and medicine. Raman spectroscopy can provide important information on molecular composition, structure, conformation, the degree of order and/or disorder, phases and phase transitions, 
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inter-and intramolecular interactions, hydrogen bonding, polymorphs, hydrates, anhydrates, molecular conformation, and polymer chain conformation. The purpose of this review is to highlight the main types of Raman spectroscopy and Raman microscopy (chemical imaging) techniques that have been successfully employed in the pharmaceutical sciences, with an emphasis on biocolloidal self-assemblies, nonaerosol drug delivery systems, and pulmonary inhalation aerosols. Additionally, this review will describe in detail the reports of Raman applications in pulmonary medicine and pharmaceutical inhalation aerosols demonstrating the potential for routine application of this powerful analytical and imaging technique in the molecular and surface characterization of inhalation aerosol delivery systems.
TYPES OF RAMAN SPECTROSCOPY

Fourier Transform Raman Spectroscopy
Fourier transform Raman (FT-Raman), the Raman method commonly used in pharmaceutical systems, prevents fluorescent background by using a longer wavelength in the near-IR region (typically 1064 nm). 12 Its success in routine pharmaceutical analysis can be attributed to its specificity (molecular fingerprint), reliability, efficiency, and cost-effectiveness as a quantitative method compared with high-pressure liquid chromatography, which always requires sample pretreatment and the use of solvents. Furthermore, it is a nondestructive and noninvasive biochemical analytical method.
Resonance-Enhanced Raman Spectroscopy
Resonance-enhanced Raman spectroscopy (RERS) occurs if the wavelength of the incoming exciting laser is near or within the electronic energy spectrum of the sample molecule, causing a resonance enhancement in the intensity of molecular vibrations. This is in contrast to conventional Raman spectroscopy, where, according to scattering theory, the wavelength of the incoming exciting laser is far below the first electronic transitions. This Raman method 13 has also been used extensively in pharmaceutical systems. Accuracy, precision, and enhanced sensitivity are all advantages in RERS.
Surface-Enhanced Raman Spectroscopy
In an effort to overcome the inherently weak Raman signals in conventional Raman methods and the ever-present problem of fluorescence of many API materials, surface-enhanced Raman spectroscopy (SERS) provides stronger Raman signals by taking advantage of electromagnetic enhancement and charge-transfer states. SERS 14 is quite useful in the study of biocolloidal dispersions (Figure 2 ), biomonomolecular layers (monolayers/nanolayers) of materials and their surfaces, including biomimetic models, biopolymers, inclusion complexes, living cells, nanoparticles, and pharmaceutical materials. Unique applications of SERS include colloidal dispersions, molecular self-assemblies, DNA/RNA mononucleotides, 15 Raman chemical imaging ( Figure 3 ) using Raman microscopy provides nondestructive, noninvasive molecular imaging capability without the use of fluorescent dyes or external markers. These advantages have vastly expanded Raman capabilities to biomacromolecular self-assemblies (eg, nucleic acid complexes and viruses), 27, 28 shown in Figure 2 , and biological media (eg, cell-based assays), with considerable application to in vitro and in vivo pharmaceutical science research. 24, 29 Incorporating an optical microscope and motorized stage into the Raman instrument for spectroscopic chemical imaging by obtaining spectra for a defined 2-dimensional area with a resolution down to 1 μm 12 has further expanded Raman spectroscopy's utility in various structural and molecular investigations. These direct and quantitative Raman chemical imaging ( Figure 3 ) and mapping ( Figure 4 ) investigations include biomaterial nanotubes (providing a spatial resolution of~25 nm), 30 drug-polymer-controlled drug delivery systems, 31, 32 solid-state polymorphic transformations, [33] [34] [35] [36] [37] and drug disposition research. 24, [38] [39] [40] [41] [42] The combination of scanning electron microscopy (SEM) and Raman spectroscopy has been applied in single-crystal hydration studies of carbamazepine, in the absence and presence of excipients, where it was demonstrated that defect structures were of greater importance in the initiation of the hydration process than the crystal face. 43 Unlabeled and unfixed single living cells and organelles can be molecularly examined rapidly, noninvasively, and nondestructively by Raman chemical imaging. This novel technique has great potential in medical applications (ex vivo and in vivo), 44 tissue engineering, and drug discovery by virtue of its noninvasive, nondestructive, and rapid molecular fingerprinting of the effects of pharmaceuticals on single living cells at various stages of the cell cycle, with detailed nanometer spatial resolution. 45 Raman chemical imaging has been used in cell biology, 46, 47 (1) reduced unwanted background signals, (2) enhanced contrast, (3) stacking, and (4) depth information via 3-D imaging resulting in high spatial and temporal resolution. Differences in chemical composition not seen in the optical image become directly apparent in the Raman image. In addition, this nondestructive imaging of chemical properties and phases is performed without extensive or special sample preparation. In sophisticated setups, complete spectra can be obtained for each image pixel, and, conversely, images can be obtained on certain parts of interest in the Raman spectrum. Confocal Raman microspectroscopy 55 has been reported to have great potential for efficiency in assessing and quantifying the physical state of a drug, physicochemical stability of the formulation, content, and homogeneity of drug distribution in a polymer formulation matrix. 56 Additionally, confocal Raman microspectroscopy has been employed in protein crystallization, 57 molecular imaging of the effects of penetration enhancers and drugs on in vivo human stratum corneum, [58] [59] [60] and in vivo human skin analysis. 61 With an elegant combination of confocal Raman spectroscopy with laser tweezers (ie, optical trapping to isolate single cells in a more natural state, as opposed to adsorption onto the surface of a solid substrate, which is known to disturb the natural state), rapid identification of single live cells (bacterial cells and fungal spores) and organelles can be accomplished from every angle. [62] [63] [64] Additionally, efforts are being made in expanding laser tweezer confocal Raman molecular application to single live cell cancer screening with a 98.3% cancer detection sensitivity based on intrinsic characteristic biomolecular differences (as opposed to physical attributes, eg, surface phenotype) in single live transformed lymphocytes and normal human lymphocytes. 65 Laser tweezer Raman spectroscopy has been used in investigating the activation of individual T cells 66 and the dynamic real-time effects of alcohol on a single living red blood cell. 67 Raman microscopy 3-D profiling has been performed with atomic force microscopy (AFM) phase imaging with confocal Raman microscopy to successfully identify and analyze, at the nanometer level, the distribution of amorphous regions on the surface of semicrystalline solid pharmaceutical excipients. 68 It was shown that Raman spectroscopy can complement AFM and can provide micrometer-level information (with lateral spatial resolution on the order of 1-2 μm) 69 on the depth of the surface amorphous domains, particularly as it applies to semicrystalline particles, in addition to characterizing bonding interactions and quantifying amorphicity/degree of crystallinity content. In addition, confocal Raman microimaging of pharmaceutical coatings in conjunction with AFM analysis has been reported in identifying the chemical composition of small areas of the coating. 70 Disadvantages of classical Raman spectroscopy, in the context of pharmaceutical applications, are fluorescence in the sample interfering with Raman scatter detectability and the inherently weak Raman scattering process, resulting in low sensitivity and the need for sensitive detectors and intense laser excitation sources. 23 SERS 16, 23, 71 overcomes these limitations by providing high sensitivity and hence is a powerful analytical technique for biocolloidal systems, antibiotic drug adsorption, 72 precise drug detection and quantification in bodily fluids, 73 and antiretroviral 74, 75 and antitubercle bacillus drug 76 molecular conformational investigations. Using a combination of micro-Raman and SERS, the recognition process of drugs with large biomolecules (eg, albumin) through the use of colloidal nanoparticles was reported through investigation of the binding properties of the drugs with albumin. 77 Surface-enhanced Raman microscopy has been successfully used in imaging of live cells, 78 including individual human lymphocyte cells. 79 SERS-confocal microscopy has been used in chemical imaging of cellular proteins, including enzymes, cellular proteins, and receptors in single cells. 80 Surfaceenhanced micro-Raman spectroscopy in model diagnostic systems incorporating microfluidics 81 showed potentially promising application in pharmaceutical research and clinical chemistry. Bacterial discrimination 82 via SEM-SERS, and viral detection in immunoassays 83 and DNA nanoimaging 84 via SERS-AFM, have been recently reported. A novel chemical nanoimaging technique combines SERS with AFM (tapping mode) to provide highly detailed spectra and highresolution chemical imaging of biological materials, including bacterial cells and DNA bases. 85 
RAMAN APPLICATIONS IN PULMONARY SYSTEMS AND PHARMACEUTICAL INHALATION AEROSOLS
Atmospheric polluting particulate matter, consisting of polyaromatic hydrocarbons and particulate soot, and its relationship to pulmonary diseases (ie, pneumonia, asthma, chronic obstructive pulmonary disease, and lung cancer), global climate change, and oceanic warming have been the subject of intense research for many decades. This is especially true in recent years, when "molecular fingerprint" characterization tools, such as Raman chemical imaging and mapping ( Figures 3 and 4, respectively) , have revealed demonstrated utility in atmospheric aerosol and bioaerosol research. Much attention has been given to bioaerosols and their relationship to various types of pulmonary allergic and infectious diseases. Additionally, the topic of infectious bioaerosols is gaining particular attention in the context of biodefense and global public health. Based on the successes of Raman spectroscopy in atmospheric and bioaerosol research, Raman applications for the respiratory system and pharmaceutical inhalation aerosols are being increasingly reported. As will be revealed in the following discussion, Raman spectroscopy has great promise for vast and powerful application in therapeutic inhalation aerosols, pulmonary histopathology, pulmonary infectious diseases, pulmonary immunology, lung surfactant biophysics and interfacial phenomena, and respiratory molecular biology.
Raman Spectroscopy in Atmospheric Aerosols and Aerosol Particulate Reactions
Raman spectroscopy has been traditionally employed in investigating and characterizing single aerosol particles, 86, 87 atmospheric aerosol particles, 88 and microparticle multicomponent aerosols. 89 Raman spectroscopy has been applied to successful in situ measurement of the chemical compositions of monodisperse and polydisperse aerosols in the micrometer size range with a low signal-to-noise ratio. 90 In situ chemical analysis of ambient uncharged atmospheric aerosol particles with diameters 9 1 μm was captured using an electrodynamic balance and levitated while Raman spectroscopy with a chargecoupled device (CCD) detector was successfully employed to identify chemical substances in the aerosol particles. 91 Raman chemical imaging using SEM and confocal laser scanning microscopy (CLSM) has also been used in the mapping of fine particulate atmospheric aerosols, 92, 93 mass and heat transfer effects on evaporating aerosol droplets, 94, 95 aerosol water droplet growth, 96, 97 single aerosol droplet physical and chemical dynamics, 98 104 and interfacial hydrogen bonding in water aerosols. 105 As seen with nonaerosol systems, enhanced Raman scattering signal was observed in aerosol chemicals analyzed by resonance Raman spectroscopy. 106 Raman microspectroscopy (Figure 3 ) has enabled the imaging and molecular fingerprinting (Figure 4 ) of hydrocarbon-water mixing during multicomponent aerosol particle formation. 107 
Raman Investigations of Bioaerosols
Raman characterization of bioaerosols, such as pollen, viruses, and bacteria, that are regularly inhaled and can cause and exacerbate pulmonary diseases has been reported. [108] [109] [110] Aerosolized aqueous suspensions of bioaerosols containing Escherichia coli, Pseudomonas aeruginosa, and Salmonella typhimurium have been examined using SERS. 111 Infectious bioaerosolized pathogens acquired by the pulmonary route have been the subject of much interest in global public health and biodefense. Bioaerosols consisting of aerosolized nanocolloidal suspensions of pollen,
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Bacillus anthracis (anthrax), 113 Francisella tularensis (tularemia), 113 and Bacillus subtilis (anthrax spores) 114 have been successfully detected at low levels and molecularly characterized by Raman chemical imaging and SERS.
Raman Studies of the Respiratory System
As mentioned previously, antimicrobial drugs used in the treatment of the pulmonary infection tuberculosis have been investigated using SERS. 76 Additionally, the various parts of the pulmonary system have been investigated using Raman spectroscopy. The interfacial properties and molecular interactions (ie, electrostatic, hydrophobic, hydrogen bonding, and van der Waals) of human lung surfactant models containing DPPC, and/or palmitoyloleoylphosphatidylglycerol (POPG), with synthetic cationic hydrophobic heteropolypeptide surfactant derivatives of human surfactant protein SP-B were deciphered by quantitative Raman interaction parameters reported by Vincent et al. 115 Additionally, they found using model human lung surfactant systems of DPPC mixed with DPPG (dipalmitoylphosphatidylglycerol) that specific lipid-heteropolypeptide interactions result in a dynamic bilayer microdomain heterogeneity 116 that is necessary for the normal mechanics of pulmonary respiration.
Various types of immortal and mortal pulmonary cell lines have been employed in many in vitro models of pulmonary transport and absorption studies of pulmonary aerosol and particulate uptake. 117 In an effort to apply powerful spectroscopic and chemical imaging techniques in the study and molecular characterization of the pulmonary system at the cellular and subcellular levels, in very recent years, Raman spectroscopy has just begun to demonstrate its unique and vast utility in noninvasive and nondestructive in vitro and in vivo pulmonary cell and subcellular applications. The molecular structure of cellular components of single lung fibroblast cells (without labeling) under stress followed by apoptosis has been examined by Raman mapping. 118 In an unlabeled single cell undergoing apoptosis, it was demonstrated that the Raman band intensity of the nucleic acids present in the nucleus and cytoplasm decreased as the number of cell surface blisters (having higher nucleic acid content) increased, which was indicative of nucleus degradation. 118 It was reported by Kaminaka et al 119, 120 that Raman spectroscopy of human lung tissue (normal and cancerous) demonstrated that 2 strong vibrational bands at 1666 and 1448 cm -1 , representing collagen, increased in lung tissues upon lung cancer progression (as noted in other cancerous tissue systems) and hence can be used as a Raman marker in diagnosis.
The molecular composition and histological evaluation of normal human bronchial tissue was characterized in situ by Raman mapping, as reported by Koljenovic et al, 121 who sought to have a biochemical and molecular understanding of lung cancer. They found that the spectra of bronchial mucus, which has relatively high quantities of triolein, were dominated by strong lipid signals, and strong collagen and glycosaminoglycan signals were associated with cartilage. Relatively lower lipid and higher DNA signals were associated with the basal side of the bronchial epithelium.
It was shown that formalin, which preserves normal and malignant human bronchial tissues, does significantly and adversely affect the Raman spectra of these tissues through the introduction of artifacts; and hence, when using fixed tissue, thorough rinsing in phosphate-buffered saline may assist in obtaining more meaningful Raman spectra. 122, 123 The authors found that formalin fixation did not affect the major Raman signals for lipids and proteins, but the Raman intensities did decrease upon formalin fixation compared with fresh unfixed human bronchial tissue. This decrease was suggested to be associated with the effect of formalin on the bronchial lipid self-assembly. In tumor tissue, the same trend was reported, particularly for the porphyrin (hemoglobin from the blood) and water Raman bands, as it related to the state of hydration of the lung tissue samples. For Raman lung tissue studies for molecular characterization of normal and lung cancer states, the authors recommended using fresh tissue rather than formalin-fixed tissue or in vivo Raman analysis.
In one study using Raman spectroscopy on fresh (unfixed and never frozen) lung tissue using normal and malignant lung tissue it was found that the normalized Raman phospholipid band intensities decreased and the amide I and amide III vibrational bands increased in lung cancer development 123, 124 as the protein content increased and protein conformational changes occurred, accompanied by increased nucleic acid content. The authors suggest that this can be attributed to the very unique organ structure of the lungs: compared with other organs, the lungs are less dense, with relatively small amounts of protein, and the density increases as the protein content increases (ie, amide I band) during disease progression.
Raman Investigations of Pharmaceutical Inhalation Aerosols
Raman spectroscopy and chemical imaging is beginning to find increasing application in the molecular characterization of pharmaceutical aerosols [125] [126] [127] for pulmonary delivery, and in particular, dry powder inhalation aerosol delivery systems. 117, 128, 129 Depicted in Figures 5 and 6 Figure 7 shows the chemical structures and molecular modeling of pulmonary inhalation aerosol carriers and excipients. The crystallinity, polymorphism, and amorphicity of α-lactose monohydrate (Figure 7a ), the only US Food and Drug Administrationapproved carrier for use in dry powder pharmaceutical aerosols, have been analyzed and distinguished using Raman spectroscopy. [130] [131] [132] [133] The molecular nature of salbutamol (albuterol) sulfate 134 ( Figure 5a ) and salts crystallized from salbutamol base 135 has been examined using Raman spectroscopy. Particle engineering techniques such as supercritical fluid (SCF) technology, solution-enhanced dispersion with supercritical fluids (SEDS), supercritical fluid extraction of emulsions, and spray-drying are used often in intelligently designing respirable dry powder particles, as described in detail by Hickey and Mansour.
117 Figure 8 illustrates the general phase diagram of an SCF, which is liquefied gas existing as a single phase above its critical point, T c , and possessing desirable properties of both its liquid (L) state and its gaseous (G) state. 117 It was reported 136 that SEDS-produced lysozyme retained biological activity as a respirable solid particle while exhibiting minor changes in its FT-Raman spectra.
Lysozyme has often been used as a robust model protein in biotherapeutic drug delivery, including dry powder inhalation aerosols for dry powder inhalers (DPIs) and aerosol propellant systems for metered-dose inhalers (MDIs). Quinn et al 137, 138 investigated the biomolecular structural conformational stability of lysozyme (predominantly α-helical conformation) and deoxyribonuclease I (predominantly β-sheet conformation) in the hydrofluoroalkane (HFA) propellants (7.5% wt/wt) tetrafluoroethane (HFA 134a) and heptafluoropropane (HFA 227) at 25-C, using FT-Raman consisting of an Nd 3+ :YAG laser at 1064 nm with a laser power of 500 mW for solids and 800 mW for suspensions. Following actuation, both proteins maintained enzymatic activity at 85% and 90% for DNase I in HFA 227 and HFA 134a, respectively, and at 94% and 91% for lysozyme in HFA 227 and HFA 134a, respectively. 137 FT-Raman provided molecular information related to secondary structure. For lysozyme structural stability in the solid state and as an aqueous 
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solution, no significant changes were observed in the C-C band (~900 cm ), the amide III band between 1264 cm -1 and 1300 cm -1 that characterized lysozyme's α-helical structure, and the disulfide band (~507 cm ) that characterized a gauche-gauche-gauche conformation. 138 The strongest propellant marker peaks were at 857 cm -1 and 839 cm -1 for HFA 227 and HFA 134a, respectively. Lysozyme maintained its structure in these propellants, as indicated from the FT-Raman spectra collected through glass vials, wherein the amide I band (1660 cm ) did not change significantly. However, the amide III band exhibited a decrease in intensity, and the authors attributed this to the effect of the local environment (aqueous vs nonaqueous propellant) on the peptide backbone conformation.
Raman spectroscopy was employed by Dem et al 126 in tracking crystallization in a droplet of mannitol (Figure 7c ) during spray-drying by monitoring polymorphism in situ. The Raman instrument (Nd: YAG laser at 532 nm) was equipped with an electrodynamic trap (at a controlled relative humidity and temperature) where a single solid particle or droplet can be levitated in the center of the trap with a 785-nm laser. The aqueous mannitol droplets, which had a diameter of 90 μm, were then charged prior to entering the trap. Single-particle Raman spectroscopy distinguished between 3 mannitol polymorphic forms during droplet evaporation at various relative humidities and temperatures, and a polymorphic phase diagram with boundary lines was constructed. 126 Dispersive Raman imaging was reported 139 in determining the particle size distribution of the commercially available combination product MDI, Combivent, which simultaneously delivers the pulmonary drugs ipratropium bromide (Figure 5b ), an anticholinergic, and albuterol sulfate (Figure 5a ), a shortacting β-agonist, in 1 actuation. The Raman peaks monitored were at 985 cm -1 and 1014 cm -1 for albuterol sulfate and ipratropium bromide, respectively, and the spectral range of 960 to 1040 cm -1 was used in Raman imaging (68-mW laser power and 100Â objective) of particles following 1 actuation and propellant evaporation. The spatial resolution was 250 nm. Raman imaging has found utility in the identification of foreign particles in a dry powder inhalation product, as reported by Kreher et al, 125 in 3 size ranges. It was found that complementary information on chemical composition was obtained for most DPI particles by SEM/X-microanalysis and Raman microprobe, and Raman-identified organics such as carbohydrates, long-chain hydrocarbons, polyethylene, and polyvinylacetal moieties in the DPI particles. 125 Dispersive Raman chemical imaging has been successfully used to determine the chemical identity and particle size distribution of active drug (eg, beclomethasone dipropionate, as shown in Figure 6c ) from among inactive compounds (carboxymethylcellulose sodium, microcrystalline cellulose, polysorbate 80, dextrose, phenylethyl alcohol, and benzalkonium chloride) in suspension-based aerosols and aqueous suspension nasal sprays containing high-dose corticosteroid, such as the commercially available nasal spray product Beconase AQ.
140, 141 Beconase AQ was used as the control, and 5 formulated aqueous nasal spray suspensions were used in the blind study. Full Raman spectra were obtained for the aqueous suspension containing corticosteroid and excipients, and chemical imaging revealed the optimal characteristic drug peak marker at 1662 cm -1 that clearly distinguished the active drug from the excipients. Particle size and shape of the drug was determined from Raman chemical imaging of dry deposits following actuation deposition onto aluminumcoated glass microscope slides.
It has been reported that red-excitation dispersive Raman spectroscopy can be applied to quantify polymorphism and amorphous content in a multicomponent dry powder formulation consisting of spray-dried mixtures of salmon calcitonin and mannitol 142 and in the study of the physical stability of these dry powder inhalation systems. 143 This technique of combining red diode laser excitation with dispersive Raman spectroscopy provides enhanced signal-to-noise ratio, higher sensitivity, and less sample heating compared with FT or dispersive Raman spectroscopy. 142 Combining a sensitive Raman system with visible excitation provides an enhanced signal-to-noise ratio, and the fluorescence background caused by visible excitation is not a limitation (as it is for biological applications) for pharmaceutical materials (excipients, biopolymers, proteins) owing to their high purity. These dry powder aerosols were analyzed by a diode laser operating at a wavelength of 669.85 nm, at a power of 250 mW, and with a spectral bandwidth of 1 cm . The digital sensor was composed of a cryogenically cooled CCD system. This particular Raman system was equipped with an aluminum cavity (1-μL volume) for a 100 to 800 μg sample such that scattered laser radiation could be reflected back into the powder sample, leading to improved signal.
Raman spectroscopy has been used on not only dry powder aerosols but also aqueous aerosol particles and propellantbased aerosol systems. Stimulated Raman scattering has been used to characterize aqueous aerosols by linear Raman spectroscopy. 144 Scanning near-IR Raman microscopy has been successfully used to map aerosol particulate deposits on the stages of an Anderson cascade impactor (ACI), as shown in Figure 9 , from a combination pressurized MDI (pMDI), Ventide. 145 ACI is the standard in vitro model of aerosol deposition in the lungs. A thorough understanding of the deposition profiles can be achieved through physicochemical investigations into the molecular and surface interactions occurring in the pulmonary inhalation aerosol delivery system (stability, adhesion, agglomeration, etc) as a function of particle size fractions based on the ACI stage deposition profiles. Aerosol deposits on stages 3 and 5 
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following a single Ventide pMDI actuation were used in Raman mapping. The Raman system used a high-performance near-IR 785-nm laser, and 10 mW of total laser energy was directed to the sample for a 30-second time scan from 1338 cm . Raman maps were 100 Â 100 μm in area, where Raman bands at 1610 cm -1 and 1662 cm -1 represented salbutamol and budesonide dipropionate, respectively. It was reported that these Raman bands for the drugs exhibited minimal interference from the pMDI excipients. Good correlation was reported between the Raman maps of the ACI plate stages and chemical analysis of the stages. Raman mapping of the stages confirmed that no new molecular bond formation (indicative of chemical degradation) in the 2 drugs occurred, based on the absence of new peaks and drug peak shifts. The authors reported that even though oleic acid may be present as a thin film on the stages, it could not be detected by Raman spectroscopy, presumably because of its low concentration, which was lower than the limit of detection.
In addition to Raman chemical imaging of combination MDI products containing an anticholinergic and a short-acting β-agonist, combination inhaled products containing a longacting β2-agonist and a corticosteroid have been investigated. Seretide MDI is a commercially available combination MDI product delivering fluticasone propionate (Figure 6a ), a corticosteroid, and salmeterol xinafoate (Figure 5c ), a longacting selective β2-agonist, in the treatment of asthma. Asthma is a complex disease state that exhibits both bronchoconstriction and airway inflammation. 146 A long-standing interest in pulmonary inhalation aerosol delivery in the treatment of asthma is the clinical observation that combination products are more efficacious than separate administration of the 2 component drugs. Perhaps this may be a result of simultaneous codeposition of both drugs on a cell via a single inhaler in a single actuation in the same inspiratory breath. Moreover, codeposition may enhance synergistic drug effects.
In an effort to gain insight into this, Theophilus et al 147 investigated the deposition per actuation from the commercially available combination and single MDI products Seretide (50 μg fluticasone propionate and 25 μg salmeterol), Serevent (25 μg salmeterol), and Flixotide (50 μg fluticasone propionate). Being an in vitro size model of the central airways, Plate 4 of the ACI, having a size range of 2.1 to 3.3 μm, was analyzed by Raman spectroscopy following MDI actuation at a flow rate of 28.3 L/min. The Raman microscope setup consisted of a 100Â objective lens, a confocal hole set at 65 μm, and a cooled CCD detector connected to a 785-nm diode laser operating at 500 mW of laser power, which provided spatial resolution of~3.2 μm. Raman chemical imaging was done on a 128 Â 128 μm area. The authors showed from their Raman chemical images that the combination inhalation product delivered from a single device had significantly greater codeposition of both drugs, which suggested that the particles in the combination MDI are associated until the particles are deposited. 147 It was acknowledged that while the ACI is an in vitro model of pulmonary deposition, the differences observed in vitro would be expected to be much greater in vivo. 147 Propellant evaporation is a rapid, dynamic, and complex interfacial process where the 
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drug interaction with the propellant can have significant effects on final particle characteristics, including particle size, morphology, and deposition behavior. This particularly pertains to 2-drug MDI systems where coassociation between the 2 drugs can favorably occur within an aerosol propellant system, as has been previously reported 148 with salmeterol and fluticasone, and was demonstrated by Raman chemical imaging of codeposition. 147 As we have recently reported, a comprehensive set of analytical techniques, including bulk and surface characterization methods, are necessary in the molecular characterization of microparticulate and nanoparticulate systems designed for pulmonary dry powder aerosol inhalation delivery. 117, 128, 129 The information on the molecular, surface, and interfacial properties that Raman characterization can provide is particularly important in applications related to respirable pharmaceutical powders, where understanding the molecular nature of these solid surfaces can enable their manipulation and tailoring for functionality at the nanometer level for targeted pulmonary delivery and deposition. Raman spectroscopy and chemical imaging are powerful analytical techniques, as detailed in this review, as they provide valuable molecular insight into a variety of biocolloidal self-assemblies and drug delivery systems, including inhalation aerosol drug delivery systems. Future Raman spectroscopy and chemical imaging investigations on pharmaceutical aerosols, particularly dry powder aerosol inhalation delivery systems, should examine the effects of temperature and relative humidity on hygroscopic particulate growth and in vitro aerosol performance, which are then correlated with phase transformations and in vitro deposition. Additionally, in vitro and in vivo Raman chemical imaging of microparticulate and nanoparticulate interactions with various living pulmonary epithelial cell types and pulmonary immune cells will provide valuable and needed biophysical insight into particulate uptake by living pulmonary cells and transport in the lungs. Moreover, Raman imaging in pulmonary medicine will enable a novel combination of molecular insight and noninvasive imaging capability that can molecularly characterize infected pulmonary cells, cancerous pulmonary cells, pulmonary disease states, and cellular delivery and disposition following pulmonary inhalation aerosol delivery.
CONCLUSIONS
As presented in this review, Raman mapping of aerosols at the micro-and nanometer level of resolution and correlation with in vitro aerosol lung deposition is now achievable with new, sophisticated, commercially available Raman microspectroscopy techniques. As has been demonstrated here, Raman chemical imaging has unique, noninvasive, and versatile applications in systems of pharmaceutical interest, and hence has vast potential for application in pulmonary inhalation aerosol research. Unique and important application potentials for Raman chemical imaging include aerosol deposition molecular profiling in the lungs and in specific individual pulmonary cells, and nondestructive chemical imaging of pulmonary aerosol inhalation delivery of biocolloidal self-assemblies and biotherapeutics, both in vitro and in vivo.
